Brief: DocGo Q3 Revenue USD 138.7 Million Vs. IBES Estimate USD 137.9 Million
07/11/2024 21:05
Nov 07 (Reuters) - DocGo Q3 gross margin 33%. * Q3 adjusted EBITDA USD 17.9 million vs. IBES estimate USD 13.6 million * Q3 net income USD 4.5 million vs. IBES estimate USD 4.35 million * outlook FY adjusted EBITDA USD 70-75 million
Recent news on DocGo
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
U.S. STOCKS ON THE MOVE-Dynatrace, Duolingo, Baidu Inc
DocGo slips on tepid quarterly results, narrower annual outlook